Firefly Neuroscience, Inc.
AIFF · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $388 | $299 | $43 | $53 |
| % Growth | 29.8% | 595.3% | -18.9% | – |
| Cost of Goods Sold | $242 | $25 | $0 | $0 |
| Gross Profit | $146 | $274 | $43 | $53 |
| % Margin | 37.6% | 91.6% | 100% | 100% |
| R&D Expenses | $378 | $336 | $312 | $437 |
| G&A Expenses | $2,007 | $1,373 | $1,588 | $1,950 |
| SG&A Expenses | $2,272 | $1,572 | $1,796 | $2,178 |
| Sales & Mktg Exp. | $265 | $199 | $208 | $228 |
| Other Operating Expenses | $152 | $0 | $0 | $874 |
| Operating Expenses | $2,802 | $1,908 | $2,108 | $3,489 |
| Operating Income | -$2,656 | -$1,634 | -$2,065 | -$3,436 |
| % Margin | -684.5% | -546.5% | -4,802.3% | -6,483% |
| Other Income/Exp. Net | $17 | -$195 | -$10,865 | -$347 |
| Pre-Tax Income | -$2,639 | -$1,829 | -$12,930 | -$3,783 |
| Tax Expense | $0 | $4 | $0 | $2 |
| Net Income | -$2,639 | -$1,833 | -$12,930 | -$3,785 |
| % Margin | -680.2% | -613% | -30,069.8% | -7,141.5% |
| EPS | -0.2 | -0.14 | -1.74 | -0.45 |
| % Growth | -42.9% | 92% | -286.7% | – |
| EPS Diluted | -0.2 | -0.14 | -1.74 | -0.45 |
| Weighted Avg Shares Out | 13,195 | 12,669 | 9,957 | 8,366 |
| Weighted Avg Shares Out Dil | 13,498 | 12,669 | 9,957 | 8,366 |
| Supplemental Information | – | – | – | – |
| Interest Income | $29 | $30 | $0 | $0 |
| Interest Expense | $10 | $15 | $128 | $33 |
| Depreciation & Amortization | $101 | $43 | $19 | $4 |
| EBITDA | -$2,403 | -$1,771 | -$12,783 | -$2,558 |
| % Margin | -619.3% | -592.3% | -29,727.9% | -4,826.4% |